All News
New Data on GLP-1s and Suicide; Sleep and Conspiracy Theories; Xanax's Dark Side
(MedPage Today) -- A meta-analysis of 27 randomized clinical trials found very low incidence of suicide-related adverse events among patients with diabetes or obesity on GLP-1 receptor agonists.
Read MoreSTAT+: ME/CFS research program shuts down at Columbia after Trump cuts
ME/CFS, which affects millions of Americans, has few dedicated research centers. Now the one at Columbia has been shut down over Trump funding cuts.
Read MorePhoenix Biotechnology, Inc. - 612178 - 12/15/2020
Finished Pharmaceuticals/Unapproved new drug
Read MoreUniversity Rx Specialists Inc - 495985 - 12/11/2018
Unapproved New Drug/Compounding/Misbranding/Adulterated
Read More